Compounds > 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone
Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Cancer of Liver

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, LH; Haas, CD; Leichman, LP; Schilcher, RB; Young, JD1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Cancer of Liver

ArticleYear
Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous schedule.
    Cancer research, 1983, Volume: 43, Issue:8

    Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Colonic Neoplasms; Cyclohexenes; Drug Administration Schedule; Drug Evaluation; Humans; Kidney Neoplasms; Kinetics; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Testicular Neoplasms

1983